Neuropsychological Profile of Children with Early and Continuously Treated Phenylketonuria: Systematic Review and Future Approaches

被引:18
作者
Canton, Marie [1 ,2 ,3 ]
Le Gall, Didier [2 ,4 ]
Feillet, Francois [1 ]
Bonnemains, Chrystele [1 ]
Roy, Arnaud [2 ,5 ,6 ]
机构
[1] Nancy Univ Childrens Hosp, Reference Ctr Inborn Errors Metab, INSERM U954, F-54000 Nancy, France
[2] Univ Angers, Lab Psychol, EA4638, UBL, F-49000 Angers, France
[3] Nancy Univ Childrens Hosp, Reference Ctr Learning Disabil, Pediat Neurol Dept, F-54000 Nancy, France
[4] Angers Univ Hosp, Dept Neurol, Neuropsychol Unit, F-49000 Angers, France
[5] Nantes Univ Hosp, Neurofibromatosis Clin, F-44000 Nantes, France
[6] Nantes Univ Hosp, Reference Ctr Learning Disabil, F-44000 Nantes, France
关键词
Phenylketonuria; children; neuropsychological profile; executive function; review; NEUTRAL AMINO-ACIDS; DEFICIT HYPERACTIVITY DISORDER; EXECUTIVE FUNCTION IMPAIRMENT; BLOOD PHENYLALANINE LEVELS; COGNITIVE FUNCTIONS; TETRAHYDROBIOPTERIN BH4; SUSTAINED ATTENTION; PREFRONTAL DYSFUNCTION; SCHOOL-ACHIEVEMENT; INHIBITORY CONTROL;
D O I
10.1017/S1355617719000146
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To provide a comprehensive systematic review of the literature by examining studies published on all cognitive aspects of children with early and continuously treated phenylketonuria (ECT-PKU) included in the databases Medline, PsycINFO, and PsycARTICLE. Method: In addition to a classical approach, we summarized methodology and results of each study in order to discuss current theoretical and methodological issues. We also examined recent advances in biochemical markers and treatments of PKU, with implications for future research on metabolic control and its role as a determinant of neuropsychological outcome. Results: Consistent with previous reviews, the hypothesis of a specific and central executive impairment in children with ECT-PKU was suggested. However, findings are inconclusive regarding the nature of executive impairments as well as their specificity, impact on everyday life, persistence over time, and etiology. Conclusion: Given the current state of the science, we suggest future directions for research that utilizes a developmental and integrative approach to examine the effects of recent advances in biochemical markers and treatment of PKU. (JINS, 2019, 25, 624-643)
引用
收藏
页码:624 / 643
页数:20
相关论文
共 137 条
[21]   VALINE, ISOLEUCINE, AND LEUCINE - A NEW TREATMENT FOR PHENYLKETONURIA [J].
BERRY, HK ;
BRUNNER, RL ;
HUNT, MM ;
WHITE, PP .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1990, 144 (05) :539-543
[22]   Phenylketonuria [J].
Blau, Nenad ;
van Spronsen, Francjan J. ;
Levy, Harvey L. .
LANCET, 2010, 376 (9750) :1417-1427
[23]   The role of intelligence in phenylketonuria: A review of research and management [J].
Brumm, V. L. ;
Grant, M. L. .
MOLECULAR GENETICS AND METABOLISM, 2010, 99 :S18-S21
[24]   Short-term memory, working memory, and executive functioning in preschoolers: Longitudinal predictors of mathematical achievement at age 7 years [J].
Bull, Rebecca ;
Espy, Kimberly Andrews ;
Wiebe, Sandra A. .
DEVELOPMENTAL NEUROPSYCHOLOGY, 2008, 33 (03) :205-228
[25]   Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria [J].
Burgard, P ;
Schmidt, E ;
Rupp, A ;
Schneider, W ;
Bremer, HJ .
EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 :S33-S38
[26]   Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: Results of a cross-national and cross-sectional study [J].
Burgard, P ;
Rey, F ;
Rupp, A ;
Abadie, V ;
Rey, J .
PEDIATRIC RESEARCH, 1997, 41 (03) :368-374
[27]   A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria [J].
Burton, B. ;
Grant, M. ;
Feigenbaum, A. ;
Singh, R. ;
Hendren, R. ;
Siriwardena, K. ;
Phillips, J., III ;
Sanchez-Valle, A. ;
Waisbren, S. ;
Gillis, J. ;
Prasad, S. ;
Merilainen, M. ;
Lang, W. ;
Zhang, C. ;
Yu, S. ;
Stahl, S. .
MOLECULAR GENETICS AND METABOLISM, 2015, 114 (03) :415-424
[28]   The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin):: a phase II, multicentre, open-label, screening study [J].
Burton, B. K. ;
Grange, D. K. ;
Milanowski, A. ;
Vockley, G. ;
Feillet, F. ;
Crombez, E. A. ;
Abadie, V. ;
Harding, C. O. ;
Cederbaum, S. ;
Dobbelaere, D. ;
Smith, A. ;
Dorenbaum, A. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (05) :700-707
[29]   Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU) [J].
Burton, Barbara K. ;
Bausell, Heather ;
Katz, Rachel ;
LaDuca, Holly ;
Sullivan, Christine .
MOLECULAR GENETICS AND METABOLISM, 2010, 101 (2-3) :110-114
[30]   Phenylketonuria Scientific Review Conference: State of the science and future research needs [J].
Camp, Kathryn M. ;
Parisi, Melissa A. ;
Acosta, Phyllis B. ;
Berry, Gerard. T. ;
Bilder, Deborah A. ;
Blau, Nenad ;
Bodamer, Olaf A. ;
Brosco, Jeffrey P. ;
Brown, Christine S. ;
Burlina, Alberto B. ;
Burton, Barbara K. ;
Chang, Christine S. ;
Coates, Paul M. ;
Cunningham, Amy C. ;
Dobrowolski, Steven F. ;
Ferguson, John H. ;
Franklin, Thomas D. ;
Frazier, Dianne M. ;
Grange, Dorothy K. ;
Greene, Carol L. ;
Groft, Stephen C. ;
Harding, Cary O. ;
Howell, R. Rodney ;
Huntington, Kathleen L. ;
Hyatt-Knorr, Henrietta D. ;
Jevaji, Indira P. ;
Levy, Harvey L. ;
Lichter-Konecki, Uta ;
Lindegren, Mary Lou ;
Lloyd-Puryear, Michele A. ;
Matalon, Kimberlee ;
MacDonald, Anita ;
McPheeters, Melissa L. ;
Mitchell, John J. ;
Mofidi, Shideh ;
Moseley, Kathryn D. ;
Mueller, Christine M. ;
Mulberg, Andrew E. ;
Nerurkar, Lata S. ;
Ogata, Beth N. ;
Pariser, Anne R. ;
Prasad, Suyash ;
Pridjian, Gabriella ;
Rasmussen, Sonja A. ;
Reddy, Uma M. ;
Rohr, Frances J. ;
Singh, Rani H. ;
Sirrs, Sandra M. ;
Stremer, Stephanie E. ;
Tagle, Danilo A. .
MOLECULAR GENETICS AND METABOLISM, 2014, 112 (02) :87-122